Statements (20)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:biotechnology
|
gptkbp:collaboratesWith |
academic researchers
biopharmaceutical companies |
gptkbp:focus |
therapeutic development
antibody discovery |
gptkbp:foundedYear |
2017
|
gptkbp:founder |
gptkb:Errik_Anderson
|
gptkbp:headquartersLocation |
gptkb:Boston,_Massachusetts,_United_States
|
https://www.w3.org/2000/01/rdf-schema#label |
Alloy Therapeutics
|
gptkbp:industry |
gptkb:biotechnology
|
gptkbp:mission |
to democratize access to foundational drug discovery technologies
|
gptkbp:notableProduct |
gptkb:ATX-Gx_humanized_mouse
gptkb:Antibody_Discovery_Services |
gptkbp:numberOfEmployees |
201-500
|
gptkbp:platform |
gptkb:ATX-Gx_mouse_platform
gptkb:Antibody_Discovery_Services |
gptkbp:type |
gptkb:public_company
|
gptkbp:website |
https://alloytx.com/
|
gptkbp:bfsParent |
gptkb:Errik_Anderson
|
gptkbp:bfsLayer |
6
|